BioAtla signs deal to sell up to $40 million in shares to Yorkville
BCAB•BioAtla entered a 36-month agreement with Yorkville to sell up to $40 million in common stock at the company’s option, replacing a $15 million agreement. BioAtla also owes a $500,000 commitment fee, with warrants covering the first installment.
1. Equity purchase agreement
BioAtla entered a 36-month standby equity purchase agreement with Yorkville on October 15, 2026, allowing it to sell up to $40 million in common stock at its option. The agreement replaces a $15 million facility, and Yorkville’s purchase price is set at 97% of the lowest daily VWAP during a three-trading-day pricing period, subject to minimum-price conditions. BioAtla owes a $500,000 commitment fee in two installments; on October 16, it issued warrants exercisable for 182,110 shares to cover the first installment, with the remainder due December 31.
